FindTrial
Sign In

A clinical trial to study the feasibility and safety of Adapted Enhanced Recovery After Surgery Pathway as compared to standard care in patients undergoing simple closure of perforated duodenal ulcer

Comparison of Adapted Enhanced Recovery After Surgery Pathway versus Standard Care following Simple Closure of Perforated Duodenal Ulcer-A Randomised Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/02/005548
Enrollment
70
Registered
2015-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients of perforated duodenal ulcer undergoing primary closure

Interventions

Intervention1: Adapted Enhanced Recovery After Surgery Pathway: NPO till first appearance of bowel sounds Patient will be assessed for bowel sounds first at 12 hours after surgery and then every 6th

Sponsors

JIPMER
Lead Sponsor
Dr VIKRAM KATE
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: all consecutive patients more than 18 years undergoing simple closure of perforated peptic ulcer less than 10mm in size

Exclusion criteria

Exclusion criteria: Age less than 18 years presence of any psychiatric or neurological illness ASA class 3 or 4 irreversible septic shock pregnancy Spontaneously sealed off perforations that did not require surgical repair multiple perforated peptic ulcers Patients having concomitant definitive surgery or additional procedures done eg TV with GJ

Design outcomes

Primary

MeasureTime frame
To compare the length of hospitalisation (LOH) in patients managed with ERAS protocol vs standard practiceTimepoint: To compare the length of hospitalisation (LOH) in patients managed with ERAS protocol vs standard practice—

Secondary

MeasureTime frame
the time elapsed until resumption of oral feeding, the need for nasogastric tube reinsertion , the need for extra analgesics , the readmission and reoperation rates mortality and morbidity during the first 30 days after surgery.Timepoint: DURING HOSPITAL STAY—

Countries

India

Contacts

Public ContactDr Vikram Kate

JIPMER

drvikramkate@gmail.com9843058013

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026